---
title: "BMPR2"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene BMPR2"
tags: ['BMPR2', 'PulmonaryArterialHypertension', 'TGFbeta', 'Mutation', 'DrugResponse', 'Treatment', 'Prognosis', 'GeneticInformation']
---

# Gene BMPR2

## Information

- **Genetic Position:** Chromosome 2:20,126,713-20,184,602
- **Pathology:** BMPR2 mutations are associated with pulmonary arterial hypertension (PAH)
- **Function:** This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. It plays a role in the signal transduction pathway of the transforming growth factor beta (TGF-beta) superfamily.

## External IDs and Aliases

- **HGNC:** BMPR2
- **NCBI Entrez:** 659
- **Ensembl:** ENSG00000108042
- **OMIM:** 600799
- **UniProtKB/Swiss-Prot:** Q13873
- **Aliases:** BMPR3, PPH1, BMPR-II, T-ALK

## AA Mutation List and Mutation Type with dbSNP ID

|Mutation|Type|dbSNP ID|
|--------|----|--------|
|p.Arg491His|Missense|rs121909575|
|p.Arg332*|Nonsense|rs121909576|
|p.Gly495Glu|Missense|rs267606622|
|p.Val347Met|Missense|rs267606623|

## Somatic SNVs/InDels with dbSNP ID

|Mutation|Type|dbSNP ID|
|--------|----|--------|
|chr2:20133282|Missense|rs781086270|
|chr2:20146681-20146682|InDel|rs8832|

## Related Disease

- Pulmonary arterial hypertension (PAH)

## Treatment and Prognosis

- PAH is a progressive and life-threatening disease with a poor prognosis. There is currently no cure for PAH, but treatments such as vasodilators, endothelin receptor antagonists, and phosphodiesterase type 5 inhibitors can improve symptoms and slow disease progression. In more advanced cases, lung transplantation may be necessary.

## Drug Response

- Patients with BMPR2 mutations may have a poorer response to certain PAH medications, such as calcium channel blockers.

## Related Papers

- Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Sharma S, Tanjore H, Tulloh RMR, Corris P, Hinderhofer K, McCabe C, Wort SJ, Danesino C, Mutti C, ... and Trembath RC (2006). "Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension." Human mutation, 27(2), 121-132. DOI: [10.1002/humu.20273]([Click](https://doi.org/10.1002/humu.20273))
- Arai Y, et al. (2000). "Germline mutations in BMPR2 gene in Japanese patients with sporadic idiopathic pulmonary hypertension." Hum Mutat, 15(4), 322â€“9. DOI: [10.1002/(SICI)1098-1004(200004)15:4<322::AID-HUMU4>3.0.CO;2-2]([Click](https://doi.org/10.1002/(SICI)1098-1004(200004)15:4%3C322::AID-HUMU4%3E3.0.CO;2-2))
- Hadinnapola C, et al. (2019). "Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension." Circulation, 139(22), 2448-2458. DOI: [10.1161/CIRCULATIONAHA.118.037831]([Click](https://doi.org/10.1161/CIRCULATIONAHA.118.037831))


Note: This information is not intended for medical diagnosis or treatment. Please consult a licensed healthcare professional for personalized medical advice.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**